Drug Shortage Report for ERWINASE

Last updated on 2021-03-16 History
Report ID 133673
Drug Identification Number 02237815
Brand name ERWINASE
Common or Proper name Erwinia L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 5 vials per box
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-02-09
Estimated end date Unknown
Actual end date 2021-03-10
Shortage status Resolved
Updated date 2021-03-16
Company comments
Health Canada comments
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-16 French Compare
v3 2021-03-16 English Compare
v2 2021-02-10 French Compare
v1 2021-02-10 English Compare